Een speciale inkt die de haren donker maakt alvorens je een laser of IPL behandeling gaat doen. Deze techniek noemen ze: carbon suspension, photosensitizer, of exogenous dye.
Wetenschappelijke studie: http://www.ncbi.nlm.nih.gov/pubmed/9311366" target="_blank
Er is een product dat heet Meladine, deze is als enige door de Amerikaanse FDA goedgekeurd voor hulp bij laser/ipl.
Het zal niet alles helpen natuurlijk, maar als het al een beetje werkt dan is dat uiteraard meegenomen. Voor hoogblond zal het waarschijnlijk niet veel uitmaken, maar als je wat blonde/rossige haartjes tussen donkere haren hebt, of je wilt je haartjes nog donkerder maken voor beter resultaat, dan kan het misschien helpen.
Meladine is a proprietary melanin enhancer that supplements the natural mela nin in hair. A patented
liposome delivery system ensures that the pigment is able to penetrate deep into the hair follicle to provide
melanin to the bulb and the bulge. The melanin deposit provides a temporary melanin-rich target in the
follicle to aid the effects of the laser.
Clearance was granted based on data from a 2 year clinical study. The study included 40 adult patients, aged
28 to 75, suffering from mild to excessive non-pigmented hair growth. Each patient was pretreated with
Meladine for 14 days prior to laser hair removal treatment. As a control group, 20 patients with non-pigmented hair growth received laser hair removal treatment without the use of a melanin enhancer.
Results from the study reveal that six months after the last laser treatment, 90% of the patients experienced
permanent hair reduction of over 75% within 10 treatments, with an average number of 7 treatments. With
an average of 8 treatments, 62.5% of the patients experienced a hair reduction of 95% or more. These results
are in contrast to 0% hair reduction experienced by the control group who did not use Meladine.
In addition to FDA clearance, several recent advances have solidified Meladine’s position as an effective
method for treating non-pigmented hair. At the annual meeting of the American Society for Dermatologic
Surgery in November, Dr. Tina Alster and Dr. Elizabeth Tanzi of the Washington Institute of Dermatologic
Laser Surgery released preliminary results from an on-going clinical trial on Meladine. Early results reveal
that 1 month after the third laser treatment, 49-54% vellus hair reduction was noted in each patient studied.
These results have triggered wide spread publicity of Meladine in several highly acclaimed publications such
as Dermatology Times, Dermascope, Allure, and Aesthetic Buyers Guide.
“While products in the past have promised the removal of non-pigmented hair, Meladine has demonstrated
lasting results time and again.” says President and CEO of Creative Technologies, Inc., Dennis R. Jones.
“There isn’t a laser hair removal facility in the world that doesn’t deal with the frustration of treating white,
gray and blonde hair—whether is it a patient that must be turned down because their hair is not the right
color , or the residual 10% vellus hairs that appear in a patient’s final treatments. We anticipate that FDA
clearance will inspire the additional confidence that doctors and laser hair removal facilities need to try
Meladine in their practices. Meladine is the safe and effective product that the laser hair removal industry has
been waiting for”
)
